Works matching Naltrexone
Results: 3346
Nitric oxide mediates effects of acute, not chronic, naltrexone on LPS-induced hepatic encephalopathy in cirrhotic rats.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2017, v. 95, n. 1, p. 16, doi. 10.1139/cjpp-2016-0188
- By:
- Publication type:
- Article
Differential effects of naltrexone on cardiac, subjective and behavioural reactions to acute ethanol intoxication.
- Published in:
- Journal of Psychiatry & Neuroscience, 2006, v. 31, n. 6, p. 386
- By:
- Publication type:
- Article
Zastosowanie naltreksonu w terapii uzależnienia od alkoholu -- aspekty farmakologiczne.
- Published in:
- Psychiatria Polska, 2013, v. 47, n. 1, p. 117
- By:
- Publication type:
- Article
Comparison of oral naltrexone and naltrexone implant treatment in alcohol use disorders.
- Published in:
- Anatolian Journal of Psychiatry / Anadolu Psikiyatri Dergisi, 2020, v. 21, n. 5, p. 477, doi. 10.5455/apd.77447
- By:
- Publication type:
- Article
Improving clinical outcomes for naltrexone as a management of problem alcohol use.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 5, p. 632, doi. 10.1111/j.1365-2125.2012.04452.x
- By:
- Publication type:
- Article
Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Revisiting the ALA/N (α-Lipoic Acid/Low-Dose Naltrexone) Protocol for People With Metastatic and Nonmetastatic Pancreatic Cancer: A Report of 3 New Cases.
- Published in:
- Integrative Cancer Therapies, 2009, v. 8, n. 4, p. 416, doi. 10.1177/1534735409352082
- By:
- Publication type:
- Article
Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 5, p. 370, doi. 10.1002/cpdd.177
- By:
- Publication type:
- Article
Single- and multiple-dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended-release oxycodone with sequestered naltrexone 40 mg twice daily to oxycontin 40 mg twice daily and extended-release oxycodone with sequestered naltrexone 80 mg once daily
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 5, p. 361, doi. 10.1002/cpdd.179
- By:
- Publication type:
- Article
The Safety and Efficacy of Low‐Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 3, p. 382, doi. 10.1002/phar.2086
- By:
- Publication type:
- Article
Naltrexone and Its Noroxymorphone Minor Metabolite - A Case Report.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Anhedonia, depression, anxiety, and craving in opiate dependent patients stabilized on oral naltrexone or an extended release naltrexone implant.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Preliminary, Open-Label Study of Naltrexone and Bupropion Combination Therapy for Treating Binge Drinking in Human Subjects.
- Published in:
- Alcohol & Alcoholism, 2020, v. 55, n. 1, p. 56, doi. 10.1093/alcalc/agz076
- By:
- Publication type:
- Article
Favorable Mortality Profile of Naltrexone Implants for Opiate Addiction.
- Published in:
- Journal of Addictive Diseases, 2010, v. 29, n. 1, p. 30, doi. 10.1080/10550880903435988
- By:
- Publication type:
- Article
Efficacy and Safety of Low Dose Naltrexone for Chronic Pain.
- Published in:
- Journal of Pain & Palliative Care Pharmacotherapy, 2024, v. 38, n. 1, p. 13, doi. 10.1080/15360288.2024.2302550
- By:
- Publication type:
- Article
Extended-release morphine sulfate and naltrexone hydrochloride (EMBEDA): naltrexone-associated withdrawal and abuse-related effects in patients with chronic pain and recreational opioid users.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Safety and Efficacy of Low-Dose Naltrexone in Patients with Fibromyalgia: A Systematic Review.
- Published in:
- Journal of Pain Research, 2023, v. 16, p. 1017, doi. 10.2147/JPR.S395457
- By:
- Publication type:
- Article
Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking Naltrexone effects on alcohol consumption: temporal effects.
- Published in:
- Psychopharmacology, 2004, v. 173, n. 1/2, p. 32, doi. 10.1007/s00213-003-1720-7
- By:
- Publication type:
- Article
Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial.
- Published in:
- Addiction, 2017, v. 112, n. 6, p. 1036, doi. 10.1111/add.13753
- By:
- Publication type:
- Article
Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial.
- Published in:
- Addiction, 2015, v. 110, n. 6, p. 1008, doi. 10.1111/add.12894
- By:
- Publication type:
- Article
Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial.
- Published in:
- Addiction, 2011, v. 106, n. 7, p. 1309, doi. 10.1111/j.1360-0443.2011.03400.x
- By:
- Publication type:
- Article
Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
- Published in:
- Addiction, 2004, v. 99, n. 7, p. 811, doi. 10.1111/j.1360-0443.2004.00763.x
- By:
- Publication type:
- Article
Evaluating the antagonist effect of naltrexone implant via opioid challenge tests with escalating doses of hydromorphone injection in former heroin dependent patients.
- Published in:
- Frontiers in Psychiatry, 2025, p. 1, doi. 10.3389/fpsyt.2025.1441598
- By:
- Publication type:
- Article
Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1240, doi. 10.3390/cancers16061240
- By:
- Publication type:
- Article
Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone.
- Published in:
- Substance Abuse: Research & Treatment, 2013, n. 7, p. 75, doi. 10.4137/SART.S10776
- By:
- Publication type:
- Article
Long-acting injectable naltrexone for the treatment of alcohol dependence.
- Published in:
- Expert Review of Neurotherapeutics, 2007, v. 7, n. 10, p. 1265, doi. 10.1586/14737175.7.10.1265
- By:
- Publication type:
- Article
Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization.
- Published in:
- Medical Sciences, 2018, v. 6, n. 4, p. 82, doi. 10.3390/medsci6040082
- By:
- Publication type:
- Article
Naltrexone Attenuates the Subjective Effects of Amphetamine in Patients with Amphetamine Dependence.
- Published in:
- Neuropsychopharmacology, 2008, v. 33, n. 9, p. 1856, doi. 10.1038/sj.npp.1301572
- By:
- Publication type:
- Article
Differences in δ- and μ-Opioid Receptor Blockade Measured by Positron Emission Tomography in Naltrexone-Treated Recently Abstinent Alcohol-Dependent Subjects.
- Published in:
- Neuropsychopharmacology, 2008, v. 33, n. 3, p. 653, doi. 10.1038/sj.npp.1301440
- By:
- Publication type:
- Article
Gene Transcription Alterations Associated with Decrease of Ethanol Intake Induced by Naltrexone in the Brain of Wistar Rats.
- Published in:
- Neuropsychopharmacology, 2007, v. 32, n. 6, p. 1358, doi. 10.1038/sj.npp.1301237
- By:
- Publication type:
- Article
Potentiation of Low Dose Ketamine Effects by Naltrexone: Potential Implications for the Pharmacotherapy of Alcoholism.
- Published in:
- Neuropsychopharmacology, 2006, v. 31, n. 8, p. 1793, doi. 10.1038/sj.npp.1300994
- By:
- Publication type:
- Article
Vivitrex®, an Injectable, Extended-Release Formulation of Naltrexone, Provides Pharmacokinetic and Pharmacodynamic Evidence of Efficacy for I Month in Rats.
- Published in:
- Neuropsychopharmacology, 2003, v. 28, n. 11, p. 1973, doi. 10.1038/sj.npp.1300274
- By:
- Publication type:
- Article
A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients.
- Published in:
- Neuropsychopharmacology, 2003, v. 28, n. 8, p. 1546, doi. 10.1038/sj.npp.1300219
- By:
- Publication type:
- Article
Effects of Naltrexone Alone and In Combination With Acamprosate on the Alcohol Deprivation Effect in Rats.
- Published in:
- Neuropsychopharmacology, 2003, v. 28, n. 8, p. 1463, doi. 10.1038/sj.npp.1300175
- By:
- Publication type:
- Article
A Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Acamprosate and Naltrexone
- Published in:
- Neuropsychopharmacology, 2002, v. 27, n. 4, p. 596, doi. 10.1016/S0893-133X(02)00368-8
- By:
- Publication type:
- Article
Ultra-trace Determination of Preconcentrationed Naltrexone using Electromembrane Extraction followed by FFT Square Wave Admittance Voltammetry in Urine Samples.
- Published in:
- Analytical & Bioanalytical Electrochemistry, 2019, v. 11, n. 9, p. 1191
- By:
- Publication type:
- Article
A comparative study on the safety and efficacy of naltrexone versus baclofen versus acamprosate in the management of alcohol dependence.
- Published in:
- Indian Journal of Psychiatry, 2020, v. 62, n. 6, p. 650, doi. 10.4103/psychiatry.IndianJPsychiatry_201_19
- By:
- Publication type:
- Article
The use of naltrexone in pathological and problem gambling: A UK case series.
- Published in:
- Journal of Behavioral Addictions, 2018, v. 7, n. 3, p. 827, doi. 10.1556/2006.7.2018.89
- By:
- Publication type:
- Article
The effects of naltrexone on retention in treatment and being opioid-free in opioid-dependent people: A systematic review and meta-analysis.
- Published in:
- Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.1003257
- By:
- Publication type:
- Article
Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey.
- Published in:
- Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.856938
- By:
- Publication type:
- Article
Evaluation of the counter-regulatory responses to hypoglycaemia in patients with type 1 diabetes during opiate receptor blockade with naltrexone.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 5, p. 615, doi. 10.1111/dom.12855
- By:
- Publication type:
- Article
Withdrawal syndrome caused by naltrexone in opioid abusers.
- Published in:
- Human & Experimental Toxicology, 2014, v. 33, n. 6, p. 561, doi. 10.1177/0960327112450901
- By:
- Publication type:
- Article
Monitoring and Improving Naltrexone Adherence in Patients with Substance Use Disorder.
- Published in:
- Patient Preference & Adherence, 2021, v. 15, p. 999, doi. 10.2147/PPA.S277861
- By:
- Publication type:
- Article
Analysis of naltrexone and its metabolite 6-β-naltrexol in serum with high-performance liquid chromatography.
- Published in:
- BMC Research Notes, 2012, v. 5, n. 1, p. 439, doi. 10.1186/1756-0500-5-439
- By:
- Publication type:
- Article
Regular Article Effect of the combination of naltrexone and acamprosate on alcohol intake in mice.
- Published in:
- Psychiatry & Clinical Neurosciences, 2004, v. 58, n. 1, p. 30, doi. 10.1111/j.1440-1819.2004.01189.x
- By:
- Publication type:
- Article
Naltrexone implant treatment for buprenorphine dependence – Mauritian case series.
- Published in:
- Journal of Psychopharmacology, 2014, v. 28, n. 8, p. 800, doi. 10.1177/0269881114528592
- By:
- Publication type:
- Article
Changes in hospital and out-patient events and costs following implant naltrexone treatment for problematic alcohol use.
- Published in:
- Journal of Psychopharmacology, 2014, v. 28, n. 8, p. 745, doi. 10.1177/0269881114536791
- By:
- Publication type:
- Article
Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance.
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 6, p. 774, doi. 10.1177/0269881110364266
- By:
- Publication type:
- Article
Acamprosate supports abstinence, Naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
- Published in:
- Journal of Psychopharmacology, 2008, v. 22, n. 1, p. 11, doi. 10.1177/0269881107078308
- By:
- Publication type:
- Article
Reduction of ethanol intake by chronic treatment with Hypericum perforatum, alone or combined with naltrexone in rats.
- Published in:
- 2005
- By:
- Publication type:
- journal article